ARCHIVES

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Letters To the Editor: Blumenthal Coverage Called “Destructive”

November 14, 1997

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990

In Brief: LYNNE PENBERTHY Was Named Associate Director For Surveillance Research In NCI’s Division of Cancer Control and Population Sciences

November 8, 2013

Summit Tells Women To Get A Mammogram, Encourages Others, Too

September 29, 1989

Weinberger, Edwards Back Away From Fight Over NCI’s Independence, Ask For Authorization Figures To Be Dropped

February 8, 1974

Neoadjuvant Surgery Makes Radiation Unnecessary In Some Early Breast Cancer

September 26, 2008